Skip to main content
SpringerLink
Log in

Statin Controversies Continued: Response to the Letter from Azemawah et al.

  • Letter to the Editor
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mach F, Ray KK, Wiklund O, Corsini A, Catapano AL, Bruckert E, et al. Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. Eur Heart J. 2018;39:2526–39.

    Article  CAS  Google Scholar 

  2. Freeman DJ, Norrie J, Sattar N, Neely RDG, Cobbe SM, Ford I, et al. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation. 2001;103:357–62.

    Article  CAS  Google Scholar 

  3. Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010;375:735–42.

    Article  CAS  Google Scholar 

  4. Shepherd J, Blauw GJ, Murphy MB, Bollen ELEM, Buckley BM, Cobbe SM, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360:1623–30.

    Article  CAS  Google Scholar 

  5. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e1082–143.

    PubMed  Google Scholar 

  6. Lee JW, Morris JK, Wald NJ. Grapefruit juice and statins. Am J Med. 2016;129:26–9.

    Article  CAS  Google Scholar 

  7. Lilja JJ, Kivisto KT, Neuvonen PJ. Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clin Pharmacol Ther. 1998;64:477–83.

    Article  CAS  Google Scholar 

  8. Lilja JJ, Neuvonen M, Neuvonen PJ. Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin. Br J Clin Pharmacol. 2004;58:56–60.

    Article  CAS  Google Scholar 

  9. Reddy P, Ellington D, Zhu Y, Zdrojewski I, Parent SJ, Harmatz JS, et al. Serum concentrations and clinical effects of atorvastatin in patients taking grapefruit juice daily. Br J Clin Pharmacol. 2011;72:434–41.

    Article  CAS  Google Scholar 

  10. Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016;388:2532–61.

    Article  CAS  Google Scholar 

  11. Amarenco P, Kim JS, Labreuche J, et al. A comparison of two LDL cholesterol targets after ischemic stroke. N Engl J Med. 2019;382:9–19.

    Article  Google Scholar 

  12. Wechsler LR. Statins and stroke — it’s complicated. N Engl J Med. 2019;382:81–2.

    Article  Google Scholar 

Download references

Author information

Author notes

  1. Brian Tomlinson and Paul Chan contributed equally to this work.

Authors and Affiliations

  1. Faculty of Medicine, Macau University of Science and Technology, Macau, 999078, China

    Brian Tomlinson & Christopher Wai Kei Lam

  2. Division of Cardiovascular Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei City, Taiwan

    Paul Chan

Authors
  1. Brian Tomlinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christopher Wai Kei Lam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Brian Tomlinson or Christopher Wai Kei Lam.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tomlinson, B., Chan, P. & Lam, C.W.K. Statin Controversies Continued: Response to the Letter from Azemawah et al.. Cardiovasc Drugs Ther 34, 887–888 (2020). https://doi.org/10.1007/s10557-020-07049-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10557-020-07049-y

Search

Navigation